You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BIOMONITOR III

Showing 1 - 25 of 9,746
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tachyarrhythmia, Atrial Fibrillation (AF), Syncope Trial in Worldwide (BIOMONITOR III and BIOMONITOR IIIm)

Completed
  • Tachyarrhythmia
  • +3 more
  • BIOMONITOR III and BIOMONITOR IIIm
  • Auchenflower, Australia
  • +26 more
Nov 2, 2022

Atrial Fibrillation, Syncope, Tachyarrhythmia Trial in Australia (BIOMONITOR III)

Completed
  • Atrial Fibrillation
  • +2 more
  • BIOMONITOR III
  • Auchenflower, Queensland, Australia
  • +6 more
May 26, 2021

Tachycardia, Atrial Fibrillation, Syncope Trial in Riga

Recruiting
  • Tachycardia
  • +4 more
    • Riga, Latvia
      Pauls Stradins Clinical University Hospital
    Nov 9, 2022

    BIOMONITOR to Identify Atrial Fibrillation in Ablation

    Terminated
    Has Results
    • Atrial Fibrillation
      • Kissimmee, Florida
      • +4 more
      Feb 7, 2022

      BIO|STREAM.ICM Obesity

      Completed
      • Tachycardia Atrial
      • +4 more
        • Castrovillari, Italy
          Ospedale Civile Ferrari
        Oct 21, 2021

        Arrhythmias, Cardiac Trial in Overland Park (Insertion of ILR device)

        Recruiting
        • Arrhythmias, Cardiac
        • Insertion of ILR device
        • Overland Park, Kansas
          Kansas City Heart Rhythm Institute
        Sep 22, 2021

        BIO|STREAM.ICM France

        Completed
        • Syncope
        • Cryptogenic Stroke
          • Clermont-Ferrand, Caen, France
          • +2 more
          Jan 3, 2022

          Atrial Fibrillation, Syncope, Tachycardia Trial in Santander (Biomonitor-2 and Kardia mobile, No Intervention)

          Recruiting
          • Atrial Fibrillation
          • +4 more
          • Biomonitor-2 and Kardia mobile
          • No Intervention
          • Santander, Spain
            Hospital Universitario Marques de Valdecilla
          Jan 9, 2023

          2 Year Follow up of COSGOD III

          Not yet recruiting
          • Neurodevelopmental Disability
          • Death
          • NIRS group
          • Graz, Austria
          • +10 more
          Nov 23, 2023

          Papillary Renal Cell Carcinoma Trial (Pembrolizumab, Placebo)

          Not yet recruiting
          • Papillary Renal Cell Carcinoma
          • (no location specified)
          Nov 24, 2023

          Resectable Melanoma, Melanoma Stage III, Melanoma (Skin) Trial in Belarus, Russian Federation (BCD-217, anti-PD1, Excision of

          Recruiting
          • Resectable Melanoma
          • +2 more
          • BCD-217
          • +3 more
          • Lesnoy, Belarus
          • +35 more
          Feb 21, 2023

          Fabry Disease Trial in Buenos Aires (Recombinant human alpha galactosidase A (agalsidase beta), Recombinant human

          Recruiting
          • Fabry Disease
          • Recombinant human alpha galactosidase A (agalsidase beta)
          • Recombinant human alpha-galactosidase A (agalsidase beta)
          • Buenos Aires, Argentina
            Instituto de Investigaciones Clínicas Quilmes
          Apr 24, 2023

          Biliary Tract Cancer, Cholangiocarcinoma Trial in Italy (Gemcitabine, Nab paclitaxel, Cisplatin)

          Not yet recruiting
          • Biliary Tract Cancer
          • Cholangiocarcinoma
          • Ancona, Italy
          • +18 more
          Sep 16, 2023

          Osteoporosis Trial in Seoul (PBK_L2201, Placebo)

          Not yet recruiting
          • Osteoporosis
          • Seoul, Korea, Republic of
            The Catholic University of Korea Yeouido Saint Mary's Hospital
          Nov 29, 2023

          Melasma Trial in Jakarta (3 % Topical Tranexamic Acid, 4% Topical Hidroquinone)

          Recruiting
          • Melasma
          • 3 % Topical Tranexamic Acid
          • 4% Topical Hidroquinone
          • Jakarta, DKI Jakarta, Indonesia
            Cipto Mangungkusumo Hospital
          Aug 21, 2023

          Machine Vision Based MDS-UPDRS III Machine Rating

          Recruiting
          • Parkinsonian Disorders
          • Machine Learning
          • video recording
          • Beijing, Beijing, China
          • +7 more
          Jun 7, 2023

          Colorectal Cancer Trial in Taipei (Colectomy with NOSE procedure)

          Recruiting
          • Colorectal Cancer
          • Colectomy with NOSE procedure
          • Taipei, Taiwan
            National Taiwan University Hospital
          Jul 23, 2023

          Decision Recommendation of Adult Skeletal Class III Patients

          Recruiting
          • Skeletal Dysplasia
          • Reverse Overjet
            • Cairo, Egypt
              Cairo University
            Aug 19, 2023

            Chronic Systolic Heart Failure Trial in China (Neucardin, Placebo)

            Recruiting
            • Chronic Systolic Heart Failure
            • Beijing, Beijing, China
            • +79 more
            Jul 9, 2023

            HR+/HER2-breast Cancer Trial (Standard endocrine therapy plus Apatinib)

            Not yet recruiting
            • HR+/HER2-breast Cancer
            • Standard endocrine therapy plus Apatinib
            • (no location specified)
            Jun 2, 2023

            Nasopharyngeal Carcinoma, Nasopharyngeal Tumors, Nasopharyngeal Diseases Trial in Guangzhou (Nimotuzumab, Cisplatin)

            Recruiting
            • Nasopharyngeal Carcinoma
            • +3 more
            • Guangzhou, Guangdong, China
              Sun Yat-sen University Cancer Center
            Nov 3, 2022

            Periodontitis, Diabetes, Type 2 Trial in Istanbul (Non-Surgical Periodontal Treatment)

            Completed
            • Periodontitis
            • Diabetes Mellitus, Type 2
            • Non-Surgical Periodontal Treatment
            • Istanbul, Turkey
              Marmara University
            Nov 11, 2023

            Lymphoma Trial in Worldwide (bleomycin sulfate, filgrastim, pegfilgrastim)

            Completed
            • Lymphoma
            • bleomycin sulfate
            • +12 more
            • Garran, Australian Capital Territory, Australia
            • +139 more
            Dec 19, 2022

            Carcinoma, Non- Small Cell Lung Trial in Worldwide (Durvalumab, Placebo)

            Active, not recruiting
            • Carcinoma, Non- Small Cell Lung
            • Long Beach, California
            • +117 more
            Oct 18, 2022

            COVID-19 Trial in Xi'an (Meplazumab for injection, Normal saline)

            Recruiting
            • COVID-19
            • Meplazumab for injection
            • Normal saline
            • Xi'an, China
              First Affiliated Hospital of the Air Force Medical University
            Apr 13, 2023